Avtar Dhillon

Executive Chairman, Emerald Health Therapeutics

Specialties: CANNABIS INVESTMENTS

Avtar Dhillon is a life sciences entrepreneur with more than 20 years’ experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering, and farming enterprises, securing government grants and NGO funding (more than $75 million US to date), and building dominant IP portfolios through partnering. During his tenure as president and CEO at Inovio (NASDAQ: INO), he led the turnaround of the company through restructuring and acquisitions.